Literature DB >> 14619979

Regulation of matrix metalloproteinases: an overview.

Sajal Chakraborti1, Malay Mandal, Sudip Das, Amritlal Mandal, Tapati Chakraborti.   

Abstract

Matrix metalloproteinases (MMPs) are a major group of enzymes that regulate cell-matrix composition. MMP genes show a highly conserved modular structure. Ample evidence exists on the role of MMPs in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, cardiovascular diseases, pulmonary diseases and cancer. The expression patterns of MMPs have interesting implications for the use of MMP inhibitors as therapeutic agents. Insights might be gained as to the preference for a general MMP inhibitor as opposed to an inhibitor designed to be specific for certain MMP family members as it relates to a defined disease state, and may give clues to potential side effects. The signalling pathways that lead to induction of expression of MMPs are still incompletely understood, but certain patterns are beginning to emerge. Regarding inhibition of MMP expression at the level of kinase pathways, it is possible that selective chemical inhibitors for distinct signalling pathways (e.g. MAPK, PKC) will hopefully, soon be available for initial clinical trials. Overexpression of selective dual specificity MAPK phosphatases have been shown to prevent MMP promoter activation which could also be used as a novel strategy to prevent activation of AP-1 and ETS transcription factors and MMP promoters in vivo. Interactions between members of different transcription factors provide fine-tuning of the transcriptional regulation of MMP promoter activity. MMPs play a crucial role in tumor invasion. Although the expression of MMPs in malignancies has been studied widely, the specific role of distinct MMPs in the progression of cancer may be more complex than has been assumed. For example, it has recently been shown that MMP-3, MMP-7, MMP-9 and MMP-12 can generate angiostatin from plasminogen, indicating that their expression in peritumoral area may in fact serve to limit angiogenesis and thereby inhibit tumor growth and invasion. The recent view about the role of stromal cells in the progression of cancer cell growth and metastasis is particularly interesting, and additional studies about the regulation of MMP gene expression and activity in malignancies are needed to understand the role and regulation of MMPs in tumor cell invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619979     DOI: 10.1023/a:1026028303196

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  128 in total

Review 1.  The AP-1 site and MMP gene regulation: what is all the fuss about?

Authors:  U Benbow; C E Brinckerhoff
Journal:  Matrix Biol       Date:  1997-03       Impact factor: 11.583

2.  Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation.

Authors:  J J Caterina; S Yamada; N C Caterina; G Longenecker; K Holmbäck; J Shi; A E Yermovsky; J A Engler; H Birkedal-Hansen
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 3.  Regulation of proteolytic activity in tissues.

Authors:  S S Twining
Journal:  Crit Rev Biochem Mol Biol       Date:  1994       Impact factor: 8.250

Review 4.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

5.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

6.  Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms.

Authors:  V Knäuper; S Krämer; H Reinke; H Tschesche
Journal:  Eur J Biochem       Date:  1990-04-30

7.  Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: regulation by vitamin A.

Authors:  J K Heath; J J Reynolds; M C Meikle
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

8.  Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

Authors:  K Imai; E Ohuchi; T Aoki; H Nomura; Y Fujii; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

9.  Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization.

Authors:  O Y Barmina; H W Walling; G J Fiacco; J M Freije; C López-Otín; J J Jeffrey; N C Partridge
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

10.  Matrix metalloprotease 2-mediated activation of Ca(2+)-ATPase by superoxide radical (O2*-) in plasma membrane of bovine pulmonary vascular smooth muscle.

Authors:  Malay Mandai; Sudip Das; Tapati Chakraborti; Sajal Chakraborti
Journal:  Indian J Biochem Biophys       Date:  2002-12       Impact factor: 1.918

View more
  334 in total

1.  Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.

Authors:  Ling Wu; Wei-Ming Chien; Matthew E Hartman; Farid Moussavi-Harami; Yonggang Liu; Michael T Chin
Journal:  Biochem Biophys Res Commun       Date:  2011-11-03       Impact factor: 3.575

2.  Matrix metalloproteinases modulated by protein kinase Cε mediate resistin-induced migration of human coronary artery smooth muscle cells.

Authors:  Qinxue Ding; Hong Chai; Nausheen Mahmood; Jerry Tsao; Daria Mochly-Rosen; Wei Zhou
Journal:  J Vasc Surg       Date:  2011-01-31       Impact factor: 4.268

3.  Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.

Authors:  Zhi-Chao Jia; Yuan-Lian Wan; Jian-Qiang Tang; Yun Dai; Yu-Cun Liu; Xin Wang; Jing Zhu
Journal:  Int J Colorectal Dis       Date:  2011-11-12       Impact factor: 2.571

4.  Association of matrix metalloproteinase gene polymorphisms with refractive error in Amish and Ashkenazi families.

Authors:  Robert Wojciechowski; Joan E Bailey-Wilson; Dwight Stambolian
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

5.  Embryonic exposure to tetrabromobisphenol A and its metabolites, bisphenol A and tetrabromobisphenol A dimethyl ether disrupts normal zebrafish (Danio rerio) development and matrix metalloproteinase expression.

Authors:  Jessica M McCormick; Michael S Paiva; Max M Häggblom; Keith R Cooper; Lori A White
Journal:  Aquat Toxicol       Date:  2010-07-23       Impact factor: 4.964

6.  Activation of the Wnt/β-catenin pathway and tissue inhibitor of metalloprotease 1 during tertiary dentinogenesis.

Authors:  Seisuke Yoshioka; Yusuke Takahashi; Makoto Abe; Ikumi Michikami; Satoshi Imazato; Satoshi Wakisaka; Mikako Hayashi; Shigeyuki Ebisu
Journal:  J Biochem       Date:  2012-10-04       Impact factor: 3.387

7.  SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Authors:  Jenna D Lovaas; Lijia Zhu; Christine Y Chiao; Vanessa Byles; Douglas V Faller; Yan Dai
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

Review 8.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

Review 9.  Matrix metalloproteinase-9 and autoimmune diseases.

Authors:  Maya Ram; Yaniv Sherer; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

10.  Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.

Authors:  Hong Li; Ashwani Mittal; Pradyut K Paul; Mukesh Kumar; Daya S Srivastava; Suresh C Tyagi; Ashok Kumar
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.